Centered Nursing Process Approach
10th Edition by McCuistion
,CONTENTS
Section I: Introduction to Pharmacology
wd wd wd wd
1. The Nursing Process and Patient-Centered Care
wd wd wd wd wd
2. Drug Development and Ethical Considerations
wd wd wd wd
3. Pharmacokinetics and Pharmacodynamics wd wd
4. Pharmacogenetics
5. Complementary and Alternative Therapies wd wd wd
6. Pediatric Considerations
wd
7. Older Adult Considerations
wd wd
8. Drugs in Substance Use Disorder
wd wd wd wd
Section II: Pharmacotherapy and Drug Administration
wd wd wd wd wd
9. Safety and Quality
wd wd
10. Drug Administration
wd
11. Drug Calculations
wd
Section III: Maintenance of Homeostasis
wd wd wd wd
12. Fluid Volume and Electrolytes
wd wd wd
13. Vitamin and Mineral Replacement
wd wd wd
14. Nutritional Support wd
Section IV: Autonomic Nervous System Drugs
wd wd wd wd wd
15. Adrenergic Agonists and Antagonists
wd wd wd
,16. Cholinergic Agonists and Antagonists
wd wd wd
Section V: Central and Peripheral Nervous System Drugs
wd wd wd wd wd wd wd
17. Stimulants
18. Depressants
19. Antiseizure Drugs wd
20. Drugs for Parkinsonism and Alzheimer‘s Disease
wd wd wd wd wd
21. Drugs for Neuromuscular Disorders and Muscle Spasms
wd wd wd wd wd wd
Section VI: Mental and Behavioral Health Drugs
wd wd wd wd wd wd
22. Antipsychotics and Anxiolytics wd wd
23. Antidepressants and Mood Stabilizers wd wd wd
Section VII: Pain and Inflammation Management Drugs
wd wd wd wd wd wd
24. Antiinflammatories
25. Analgesics
Section VIII: Antimicrobial Drugs
wd wd wd
26. Antibacterials
1. Section A: Penicillins and Cephalosporins
wd wd wd wd
2. Section B: Macrolides and Tetracyclines
wd wd wd wd
3. Section C: Aminoglycosides and Fluoroquinolones
wd wd wd wd
4. Section D: Sulfonamides and Metronidazole
wd wd wd wd
27. Antituberculars, Antifungals, and Antivirals wd wd wd
28. Antimalarials, Anthelmintics, and Peptides
wd wd wd
, Section IX: Immunologic Drugs
wd wd wd
29. HIV- and AIDS-Related Drugs
wd wd wd
30. Transplant Drugs wd
31. Vaccines
Section X: Antineoplastics and Biologic Response Modifiers
wd wd wd wd wd wd
32. Anticancer Drugs wd
33. Targeted Therapies to Treat Cancer
wd wd wd wd
34. Biologic Response Modifiers
wd wd
Section XI: Respiratory Drugs
wd wd wd
35. Upper Respiratory Disorders
wd wd
36. Lower Respiratory Disorders
wd wd
Section XII: Cardiovascular Drugs
wd wd wd
37. Cardiac Glycosides, Antianginals, and Antidysrhythmics
wd wd wd wd
38. Diuretics
39. Antihypertensives
1. Section A: Beta Blockers
wd wd wd
2. Section B: Alpha Blockers
wd wd wd
3. Section C: Drugs Affecting RAAS
wd wd wd wd
4. Section D: Calcium Channel Blockers
wd wd wd wd
40. Anticoagulants, Antiplatelets, and Thrombolytics
wd wd wd
41. Antihyperlipidemics and Drugs to Improve Peripheral Blood
wd wd wd wd wd wd